NTRS
62
5
SIG
54
2
KEY
55
2
ROP
56
3
LH
38
2
V
62
10
RF
54
3
MDLZ
38
2
GOOG
67
4
ED
39
2
UAL
77
4
F
47
3
NWL
54
5
DOW
44
4
MMC
62
2
PPL
60
3
PYPL
52
7
EMR
54
4
ECL
72
2
HPE
50
4
NTRS
62
5
SIG
54
2
KEY
55
2
ROP
56
3
LH
38
2
V
62
10
RF
54
3
MDLZ
38
2
GOOG
67
4
ED
39
2
UAL
77
4
F
47
3
NWL
54
5
DOW
44
4
MMC
62
2
PPL
60
3
PYPL
52
7
EMR
54
4
ECL
72
2
HPE
50
4
Financhill
Back

Direxion Daily Real Estate Bull 3X ETF Vs. Kymera Therapeutics Industry Stock Comparison

Buy
73

DRN
Direxion Daily Real Estate Bull 3X ETF

Last Price:
13.35
Seasonality Move:
13.81%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
48.99
Seasonality Move:
65.72%
Buy
73
Direxion Daily Real Estate Bull 3X ETF (DRN) is a Buy

Is Direxion Daily Real Estate Bull 3X ETF a Buy, Sell or Hold?

  • The current Direxion Daily Real Estate Bull 3X ETF [DRN] share price is $13.32. The Score for DRN is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • DRN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DRN Stock Price Chart

What is Direxion Daily Real Estate Bull 3X ETF's stock price today?

  • The Direxion Daily Real Estate Bull 3X ETF share price today is $13.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 59.9 Buy
Chaikin Money Flow: 562428 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.43 - 13.59) Buy
Bollinger Bands (100): (8.96 - 12.68) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

DRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.41 Buy
20-day SMA: 12.86 Buy
50-day SMA: 12.43 Buy
200-day SMA: 9.92 Buy
8-day EMA: 12.69 Buy
20-day EMA: 12.71 Buy
50-day EMA: 12.25 Buy
200-day EMA: 10.44 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Direxion Daily Real Estate Bull 3X ETF Earnings Growth & DRN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Direxion Daily Real Estate Bull 3X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):